Amtech Systems enters its May 7 earnings report as one of the more interesting small-cap setups in semiconductor equipment right now — not because short sellers are piling in, but because the cost of borrowing its shares has exploded while the stock has staged a remarkable one-month rally.
The borrow story is the headline. Cost to borrow has risen from roughly 0.07% in late March to 3.29% today — a more than fortyfold move in six weeks, with an interim peak of 4.88% on April 16. That spike is sharp enough to suggest genuine demand for borrows has picked up, even though availability remains extremely loose at roughly 998% of short interest. With around 10 shares available to lend for every one already shorted, there is no mechanical squeeze pressure. The borrow cost move looks more like a small-cap liquidity effect amplified by the stock's dramatic price action than any sign of a crowded short trade.
Short interest itself tells a moderate story. At 3.1% of the free float, with about 320,000 shares short, the position is neither large nor extreme. The week-on-week count ticked up roughly 11%, reversing a multi-week decline — but from early March, when shorts ran above 440,000 shares, the overall trend has been unwinding. Days to cover check in at 1.25, barely over a day's worth of volume. The ORTEX short score of 34.9 ranks in the middle of the universe. Nothing here points to an aggressive short thesis building ahead of results.
Options traders are also leaning bullish rather than defensive. The put/call ratio has dropped sharply to 0.116, well below its 20-day mean of 0.171 and near the lower end of the past year's range. That's more than one standard deviation below average in the other direction — call flow is dominating. Given that the stock has gained 45% in a month, this positioning reflects momentum-chasing rather than hedging ahead of what has historically been a bruising earnings event.
The earnings history is worth reading carefully. At the February 5 print, ASYS fell 29.4% in a single session and shed another point over the following week, for a five-day loss of 30.2%. A prior print also saw a 9.8% single-day drop. The two data points in the snapshot both point to pronounced downside reactions around results. The stock's current configuration — up 45% in a month, options market skewed to calls, shorts below their recent peak — is the inverse of where things stood heading into those events.
Institutional ownership adds another dimension. The top two holders, Wax Asset Management and Robert Averick, together control roughly 30% of shares outstanding. Averick, who also sits on the board as an independent director, was an aggressive open-market buyer at prices around $3.46–$3.54 last May — roughly one-fifth of the current $16.60 price. His most recent March 2026 activity was a routine director stock award at zero cost. Chairman and CEO Robert Daigle also bought in May 2025 across three sessions, spending around $27,000. Those purchases came near the stock's lows; the stock has since rallied substantially. No open-market purchases appear in the 90-day window ending March 2026.
Analyst coverage is thin and stale — the most recent rating change on record is a Benchmark downgrade to Hold from December 2023, with a mean price target of $16.00 as of February 2026. The stock is effectively trading in line with that target now. With no fresh analyst activity to speak of, the Street is essentially a spectator into this print. The RSI sits at 57.8, consistent with momentum without being technically overbought.
The question on May 7 is whether the results can justify a stock that has nearly tripled from its lows in under a year — and whether the options market's call-heavy lean reflects genuine conviction or simply the inertia of a strong trend.
See the live data behind this article on ORTEX.
Open ASYS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
